FDA Recall of Various Eye Drop Brands Over Sterility Concerns
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
K.C. Pharmaceuticals, Inc. is recalling 303,216 bottles of multiple eye drop products distributed nationwide due to a lack of assurance of sterility.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 14, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Eye Drops.
What Happened
K.C. Pharmaceuticals, Inc. is recalling certain eye drop products because of a lack of assurance of sterility, as classified by the FDA as a Class II recall.
Which Products Are Affected
The affected products include various eye drops such as: a) Walgreens Advanced Relief Eye Drops, UPC 3 11917 20074 3; b) Kroger Advanced Relief Eye Drops; c) CVS Health Advanced Relief Eye Drops, UPC 0 50428 43544 1; d) QC-Quality Choice Moisturizing Relief Eye Drops, NDC 83324-191-14; e) Discount Drug Mart Eye Drops, UPC 0 93351 01155 9; f) Foster & Thrive Advanced Relief Eye Drops, NDC 70677-1158-1; g) GoodSense Eye Drops Advanced Relief Moisturizer, NDC 50804-130-01; h) TopCare Health Eye Drops, UPC 0 36800 03641 3; i) DG Health Sterile Eye Drops, UPC 0 95072 02556 3; and j) Code Red Eye Drops Redness Relief, NDC 83817-963-01. A total of 303,216 bottles are affected, with specific lots including AR24D01 (exp. 04/30/26), AR24G01 (exp. 07/31/26), AR24G02 (exp. 07/31/26), and AR24M01 (exp. 10/31/26). These products were distributed nationwide in the US.
What You Should Do
Consumers who have the affected eye drops should immediately stop using them and contact the recalling firm, K.C. Pharmaceuticals, Inc., for instructions on returns or refunds. The initial notification was made via e-mail.
Why This Matters
This recall is significant because unsterile eye drops could potentially lead to eye infections, posing a risk to consumer health. It affects a large number of products distributed across the United States, highlighting the importance of sterility in ophthalmic drugs.
Source
FDA recall notice for recall number D-0410-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,668 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 14, 2026.
Frequently Asked Questions
Common questions about this FDA recall.